The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Clinical Course of Multiple Sclerosis
Open accessAbstract
The 1996 originally established multiple sclerosis (MS) subtypes, based solely on clinical impression and consensus, were revised in 2013 to review potential imaging and biological correlates and to reflect recently identified clinical aspects of MS. As a result, potential new disease phenotypes, radiologically isolated syndrome, and clinically isolated syndrome were considered along with the addition of two new descriptor subtypes: activity and progression applied to relapsing remitting and progressive MS phenotypes. In this way, the description of an individual patient's disease course is refined and provides temporal information about the ongoing disease process. There is still a lack of imaging and biological markers that would distinguish MS phenotypes and prognosticate the disease course on an individual patient's level, creating a pressing need for large collaborative research efforts in this field.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Compston, A., & Coles, A. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61620-7 · Cited by 4,372
New Multiple Sclerosis Phenotypic Classification
Lublin, F. D. (2014) · European Neurology · doi:10.1159/000367614 · Cited by 4,259
Self-citationDefining the clinical course of multiple sclerosis: Results of an international survey
Lublin, F. D., Reingold, S. C., & National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis* (1996) · Neurology · doi:10.1212/wnl.46.4.907 · Cited by 3,686
Self-citationDefining the clinical course of multiple sclerosis: The 2013 revisions
Lublin, F. D., Reingold, S. C., Cohen, J. A., Cutter, G. R., Sørensen, P. S., Thompson, A. J., Wolinsky, J. S., Balcer, L. J., Banwell, B., Barkhof, F., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000000560 · Cited by 3,177
Self-citationRate of Pregnancy-Related Relapse in Multiple Sclerosis
Confavreux, C., Hutchinson, M., Hours, M. M., Cortinovis-Tourniaire, P., & Moreau, T. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807303390501 · Cited by 1,559
Relapses and Progression of Disability in Multiple Sclerosis
Confavreux, C., Vukusic, S., Moreau, T., & Adeleine, P. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011163432001 · Cited by 1,309
Barkhof, F. (1997) · Brain · doi:10.1093/brain/120.11.2059 · Cited by 1,251
The Immunopathology of Multiple Sclerosis: An Overview
Lassmann, H., Brück, W., & Lucchinetti, C. F. (2007) · Brain Pathology · doi:10.1111/j.1750-3639.2007.00064.x · Cited by 1,182
A longitudinal study of abnormalities on MRI and disability from multiple sclerosis
Brex, P. A., Ciccarelli, O., O'Riordan, J. I., Sailer, M., Thompson, A. J., & Miller, D. H. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011341 · Cited by 861
Incidental MRI anomalies suggestive of multiple sclerosis: The radiologically isolated syndrome
Okuda, D. T., Mowry, E. M., Beheshtian, A., Waubant, E., Baranzini, S. E., Goodin, D. S., Hauser, S. L., & Pelletier, D. (2009) · Neurology · doi:10.1212/01.wnl.0000335764.14513.1a · Cited by 642
WEINSHENKER, B. G., BASS, B., RICE, G. P. A., NOSEWORTHY, J., CARRIERE, W., BASKERVILLE, J., & EBERS, G. C. (1989) · Brain · doi:10.1093/brain/112.6.1419 · Cited by 602
Miller, D. H., Chard, D. T., & Ciccarelli, O. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70274-5 · Cited by 507
Multiple Sclerosis Risk After Optic Neuritis: Final Optic Neuritis Treatment Trial Follow-up
(2008) · Archives of Neurology · doi:10.1001/archneur.65.6.727 · Cited by 476
Kremenchutzky, M., Rice, G. P. A., Baskerville, J., Wingerchuk, D. M., & Ebers, G. C. (2006) · Brain · doi:10.1093/brain/awh721 · Cited by 447
Effect of relapses on development of residual deficit in multiple sclerosis
Lublin, F. D., Baier, M., & Cutter, G. (2003) · Neurology · doi:10.1212/01.wnl.0000096175.39831.21 · Cited by 421
Self-citationEarly onset multiple sclerosis: A longitudinal study
Boiko, A., Vorobeychik, G., Paty, D., Devonshire, V., Sadovnick, D., & Neurologists*, T. U. M. C. (2002) · Neurology · doi:10.1212/wnl.59.7.1006 · Cited by 417
Association between stressful life events and exacerbation in multiple sclerosis: a meta-analysis
Mohr, D. C., Hart, S. L., Julian, L., Cox, D., & Pelletier, D. (2004) · BMJ · doi:10.1136/bmj.38041.724421.55 · Cited by 401
Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis?
Tintoré, M., Rovira, A., Río, J., Tur, C., Pelayo, R., Nos, C., Téllez, N., Perkal, H., Comabella, M., Sastre-Garriga, J., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000280576.73609.c6 · Cited by 345
Radiologically isolated syndrome: 5-year risk for an initial clinical event
Okuda, D. T., Siva, A., Kantarci, O., Inglese, M., Katz, I., Tutuncu, M., Keegan, B. M., Donlon, S., Hua, L. H., Vidal-Jordana, A., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090509 · Cited by 339
Multiple sclerosis—a quiet revolution
Ransohoff, R. M., Hafler, D. A., & Lucchinetti, C. F. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.14 · Cited by 338
Secondary progressive multiple sclerosis: current knowledge and future challenges
Rovaris, M., Confavreux, C., Furlan, R., Kappos, L., Comi, G., & Filippi, M. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70410-0 · Cited by 303
Overview of the epidemiology, diagnosis, and disease progression associated with multiple sclerosis.
Tullman, M. J. (2013) · PubMed · Cited by 257
Weiner, H. L. (2008) · Journal of Neurology · doi:10.1007/s00415-008-1002-8 · Cited by 255
B cells and antibodies in CNS demyelinating disease
Cross, A. H., Trotter, J. L., & Lyons, J.-A. (2001) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(00)00409-4 · Cited by 251
Langer-Gould, A., Popat, R. A., Huang, S. M., Cobb, K., Fontoura, P., Gould, M. K., & Nelson, L. M. (2006) · Archives of Neurology · doi:10.1001/archneur.63.12.1686 · Cited by 229
Brainstem lesions in clinically isolated syndromes
Tintore, M., Rovira, A., Arrambide, G., Mitjana, R., Río, J., Auger, C., Nos, C., Edo, M. C., Castilló, J., Horga, A., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181feb26f · Cited by 197
Mechanisms of action of interferons and glatiramer acetate in multiple sclerosis
Dhib-Jalbut, S. (2002) · Neurology · doi:10.1212/wnl.58.8_suppl_4.s3 · Cited by 184
Diagnostic uncertainty during the transition to secondary progressive multiple sclerosis
Katz Sand, I., Krieger, S., Farrell, C., & Miller, A. E. (2014) · Multiple Sclerosis Journal · doi:10.1177/1352458514521517 · Cited by 182
Axonal degeneration in multiple sclerosis: The mitochondrial hypothesis
Su, K., Banker, G. A., BOURDETTE, D. N., & Forte, M. A. (2009) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-009-0060-3 · Cited by 157
Imaging biomarkers in multiple sclerosis
Filippi, M., & Agosta, F. (2010) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.22102 · Cited by 143
The natural history of relapses in multiple sclerosis
Vollmer, T. L. (2007) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2007.01.065 · Cited by 131
Early Relapses, Onset of Progression, and Late Outcome in Multiple Sclerosis
Scalfari, A., Neuhaus, A., Däumer, M., DeLuca, G. C., Muraro, P. A., & Ebers, G. C. (2012) · JAMA Neurology · doi:10.1001/jamaneurol.2013.599 · Cited by 126
Relapses and disability accumulation in progressive multiple sclerosis
Soldán, M. M. P., Novotná, M., Zeid, N. E. A., Kale, N., Tütüncü, M., Crusan, D. J., Atkinson, E. J., Sıva, A., Keegan, B. M., Pirko, I., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000001094 · Cited by 114
Body fluid biomarkers for multiple sclerosis—the long road to clinical application
Teunissen, C. E., Malekzadeh, A., Leurs, C., Bridel, C., & Killestein, J. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.173 · Cited by 106
Th17 cells in central nervous system autoimmunity
Sie, C., Korn, T., & Mitsdoerffer, M. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.03.009 · Cited by 96
Magnetization Transfer MRI in Multiple Sclerosis
Filippi, M., & Agosta, F. (2007) · Journal of Neuroimaging · doi:10.1111/j.1552-6569.2007.00132.x · Cited by 90
Spinal-Cord MRI in Multiple Sclerosis: Conventional and Nonconventional MR Techniques
Bot, J., & Barkhof, F. (2008) · Neuroimaging Clinics of North America · doi:10.1016/j.nic.2008.09.005 · Cited by 78
Update on the pathogenesis of Parkinson’s disease
Schulz, J. B. (2008) · Journal of Neurology · doi:10.1007/s00415-008-5011-4 · Cited by 72
Clinically isolated acute transverse myelitis: prognostic features and incidence
Young, J., Quinn, S. J., Hurrell, M., & Taylor, B. V. (2009) · Multiple Sclerosis Journal · doi:10.1177/1352458509345906 · Cited by 68
Filippi, M., & Rocca, M. A. (2011) · PubMed · Cited by 16
Cited by
Roles of neuropathology-associated reactive astrocytes: a systematic review
Lawrence, J. M., Schardien, K., Wigdahl, B., & Nonnemacher, M. R. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01526-9 · Cited by 433
Reassessing B cell contributions in multiple sclerosis
Li, R., Patterson, K. R., & Bar-Or, A. (2018) · Nature Immunology · doi:10.1038/s41590-018-0135-x · Cited by 401
Gadhave, D. G., Sugandhi, V. V., Jha, S. K., Nangare, S. N., Gupta, G., Singh, S. K., Dua, K., Cho, H., Hansbro, P. M., & Paudel, K. R. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102357 · Cited by 358
Microglial NLRP3 inflammasome activation in multiple sclerosis
(2020) · Advances in Protein Chemistry and Structural Biology · doi:10.1016/bs.apcsb.2019.08.007 · Cited by 83
Broos, J. Y., van der Burgt, R. T. M., Konings, J., Rijnsburger, M., Werz, O., de Vries, H. E., Giera, M., & Kooij, G. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02981-w · Cited by 41
Metadata
- Authors
- Klineova, S., & Lublin, F. D.
- Venue
- Cold Spring Harbor Perspectives in Medicine
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2018-01-22
- Volume
- 8
- Issue
- 9
- Pages
- a028928
- ISSN
- 2157-1422 (ISSN-L)
- OpenAlex
- W2784859886
- Cited by
- 401
- References
- 41
- Type
- posted content
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.